Cargando…
Retracted: Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer
Autor principal: | and Alternative Medicine, Evidence-Based Complementary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307335/ https://www.ncbi.nlm.nih.gov/pubmed/37388014 http://dx.doi.org/10.1155/2023/9831949 |
Ejemplares similares
-
Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Identification of Novel CircRNA-miRNA-mRNA Regulatory Network and Its Prognostic Prediction in Breast Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: An Immune-Related Prognostic Risk Model in Colon Cancer by Bioinformatics Analysis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: In Silico Identification of Hub Genes as Observing Biomarkers for Gastric Cancer Metastasis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)